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Egress from infected RBCs is a critical,
but poorly understood, step in themalaria
parasite’s lifecycle. Das et al. report that
just prior to egress, proteolytic
processing of parasite surface protein
MSP1 activates a spectrin binding
function, allowing the intracellular
parasite to interact with the RBC
cytoskeleton and enabling egress.
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The malaria parasite Plasmodium falciparum repli-
cates within erythrocytes, producing progeny mero-
zoites that are released from infectedcells via apoorly
understood process called egress. The most abun-
dant merozoite surface protein, MSP1, is synthesized
as a large precursor that undergoes proteolytic matu-
ration by the parasite protease SUB1 just prior to
egress. The function of MSP1 and its processing are
unknown. Here we show that SUB1-mediated pro-
cessing of MSP1 is important for parasite viability.
Processing modifies the secondary structure of
MSP1 and activates its capacity to bind spectrin, a
molecular scaffold protein that is the major compo-
nent of the host erythrocyte cytoskeleton. Parasites
expressing an inefficiently processed MSP1 mutant
show delayed egress, and merozoites lacking sur-
face-bound MSP1 display a severe egress defect.
Our results indicate that interactions between SUB1-
processed merozoite surface MSP1 and the spectrin
network of the erythrocyte cytoskeleton facilitate
host erythrocyte rupture to enable parasite egress.
INTRODUCTION
Malaria is a debilitating and often fatal infectious disease of trop-
ical and subtropical regions. All associated pathology arises from
intraerythrocytic replication of the protozoan parasite Plasmo-
dium. For most of its erythrocytic life cycle, which lasts 48 hr
in the most dangerous species, P. falciparum, the parasite re-
sides within a parasitophorous vacuole (PV), sequestered from
the host cell cytosol. Parasite growth leads to formation of a
multinucleated schizont. Merozoites, polarized cells specialized
for erythrocyte invasion, budoff from themature schizont. Shortly
thereafter, the PV membrane (PVM) ruptures, releasing the nowCell Hostfreely mobile progeny merozoites into the residual erythrocyte
cytosol. Within seconds, rupture of the host cell membrane al-
lows egress of the merozoites to invade fresh erythrocytes (for
a review of egress see Blackman and Carruthers, 2013).
At least 40 proteins localize to themerozoite surface (Cowman
et al., 2012). Many of these traffic to the parasite plasma mem-
brane during schizont development, where they are tethered
via glycosyl phosphatidylinositol (GPI) anchors or through pe-
ripheral associations with GPI-anchored proteins. The most
abundant merozoite surface component, a GPI-anchored pro-
tein called MSP1, is synthesized as an 200 kDa protein that
in P. falciparum associates with at least two other peripheral pro-
teins belonging to the MSP3 and MSP7 families (Kauth et al.,
2006; Lin et al., 2014; Pachebat et al., 2001; Trucco et al.,
2001). MSP1 is conserved throughout Plasmodium and has
been scrutinized as a result of its capacity to induce antibody re-
sponses that inhibit parasite replication in vitro or protect in vivo
(reviewed by Holder, 2009). Gene targeting experiments suggest
that MSP1 is essential in the haploid blood stages (Combe et al.,
2009; Drew et al., 2004; O’Donnell et al., 2000), but msp1 null
mutants could not be established so these studies provided little
insight into MSP1 function. Bioinformatic analyses have been
similarly uninformative, since MSP1 has no orthologs outside
Plasmodium and structural information is sparse. The merozoite
surface location of MSP1 has provoked speculation that it func-
tions in erythrocyte invasion. Supporting this are reports that
MSP1 binds to erythrocyte glycophorin A (Baldwin et al., 2015;
Su et al., 1993), Band 3 (Goel et al., 2003; Li et al., 2004), and
heparin-like molecules (Boyle et al., 2010; Zhang et al., 2013),
while heparin and related polysaccharides block invasion by
P. falciparum merozoites (Boyle et al., 2010; Clark et al., 1997;
Crick et al., 2014; Kulane et al., 1992; Zhang et al., 2013). How-
ever, it remains to be demonstrated that MSP1 plays a primary
role in invasion, and a mechanistic understanding of MSP1 func-
tion is lacking.
Minutes before egress, a serine protease called SUB1 is dis-
charged from merozoite secretory organelles into the PV
lumen, where it cleaves MSP1 and its partner proteins (Kous-
sis et al., 2009; Silmon de Monerri et al., 2011; Yeoh et al.,& Microbe 18, 433–444, October 14, 2015 ª2015 The Authors 433
Figure 1. Alternative 38/42 Processing Sites
in MSP1
(A) P. falciparum MSP1 and primary processing
products. Known and predicted PfSUB1 cleav-
age sites in MSP1-D and MSP1-F (colored hori-
zontal bars), above an alignment of flanking se-
quences, with experimentally confirmed cleavage
sites arrowed and indicated by gaps. The 38/42
region contains the canonical cleavage site (can)
as well as two additional sites (alt1 and alt2)
confirmed in this work. MSP1-F contains a further
predicted 38/42 site (HVGAEYSNTIT; green bar)
but this study found no evidence for cleavage at
that site.
(B) Cleavage by rPfSUB1 of peptides based on
alternative 38/42 processing sites. RP-HPLC
elution profiles of N-acetylated decapeptides
before or after incubation with rPfSUB1. Parental
peptide peaks diminished over time, with
concomitant increase in the indicated products.
In the case of Ac-PIFGESEDND the C-terminal
cleavage product was too hydrophilic to bind to
the RP-HPLC column. The small peak near the
end of each chromatogram that does not alter
with time represents elution of detergent from the
digestion buffer.
(C) The 38/42alt1 peptides are better substrates
than the canonical 38/42 site peptides. Equimolar
mixtures of peptides based on the canonical 38/42
and 38/42alt1 sites in MSP1-F and MSP1-D were
incubated with rPfSUB1 and the peak area for
substrate and product(s) monitored with time.
Initial cleavage rates were compared after no more
than 10% of the fastest cleaved peptide had been
hydrolyzed, though for clarity extended digestions
are also shown. Cleavage of both 38/42alt1 pep-
tides occurred at least 6.7 times faster than
cleavage of the corresponding canonical 38/42
site peptide. See also Figure S1.2007). P. falciparum MSP1 is converted in this primary pro-
cessing step into four fragments, which initially remain in
a non-covalent complex on the merozoite surface (Holder
et al., 1987; McBride and Heidrich, 1987). Following egress,
MSP1 is further cleaved at a juxtamembrane site by a second
parasite protease called SUB2 (Harris et al., 2005), shedding
the bulk of the MSP1 complex (Blackman et al., 1991; Riglar
et al., 2011). Spatiotemporal regulation of these processing
steps is important for parasite viability (Child et al., 2010).
Discharge of SUB1—and hence the timing of primary process-
ing—is controlled by a parasite protein kinase (PKG), and inhi-
bition of SUB1 discharge or activity prevents egress (Collins
et al., 2013b; Taylor et al., 2010; Yeoh et al., 2007). Despite
these insights, the role of MSP1 processing is unknown and
a picture of how events following SUB1 discharge lead to
rupture of the bounding membranes and erythrocyte cytoskel-
eton has yet to be established.
Here we show that processing by SUB1 enables MSP1 to
interact with the host cell cytoskeleton to play a previously un-
suspected role in egress.434 Cell Host & Microbe 18, 433–444, October 14, 2015 ª2015 The ARESULTS
Alternative SUB1 Processing Sites in MSP1
P. falciparum MSP1 is a polymorphic protein that exists in two
major isoforms, typified by those of the 3D7 and FCB1 parasite
isolates. N-terminal sequencing has mapped three positionally
conserved primary processing sites in each of these MSP1 iso-
forms (Blackman et al., 1991; Cooper and Bujard, 1992; Heidrich
et al., 1989;Koussis et al., 2009;Staffordet al., 1994). Thesitesare
referred to as 83/30, 30/38, and 38/42, after the approximate
massesof the cleavageproducts (Figure 1A).While all are cleaved
by P. falciparum SUB1 (PfSUB1), they are structurally distinct,
consistent with evidence that PfSUB1 accommodates flexibility
in its recognition motif (Withers-Martinez et al., 2012). Only the
38/42 site (i.e., that closest to the C terminus of MSP1) shows sig-
nificant similarity between 3D7MSP1 (MSP1-D) and FCB1MSP1
(MSP1-F) (Figure 1A). Cleavage at the 38/42 site is a rate-limiting
processing step (Child et al., 2010), implying special importance.
Since the identification of SUB1 as the enzyme responsible for
MSP1 processing, the possibility of additional processing sitesuthors
has not been explored. PfSUB1 substrate recognition is domi-
nated by a preference for an aliphatic residue at the P4 position
(numbering according to (Schechter and Berger, 1967), a small
uncharged residue at P2, a polar residue at P1, and acidic resi-
dues at one or more of the P10–P50 positions (Withers-Martinez
et al., 2012). In early work examining cleavage of recombinant
MSP1-D in parasite extracts, Cooper and Bujard (1992) identi-
fied two additional cleavage sites adjacent to the canonical 38/
42 site, suggesting redundancy. These motifs (VVQLQYNYDEE
and PIFGEYSEDND in MSP1-D), which are partially conserved
in MSP1-F (Figure 1A), bear hallmarks of PfSUB1 sites, so we
tested whether recombinant PfSUB1 (rPfSUB1) could cleave
peptides based on them. All were cleaved at their central bond
(Figure 1B), suggesting that both the alternative 38/42 sites in
MSP1-D, and at least one of the alternative sites in MSP1-F,
might be authentic processing sites. As both lie close to the ca-
nonical 38/42 site, they are referred to as the 38/42alt1 and 38/
42alt2 sites (Figure 1A). In kinetic assays, the 38/42alt1 peptides
from both MSP1 isoforms were cleaved 7-fold faster than the
respective canonical 38/42 peptides (Figure 1C), an observation
important for subsequent work.
Mutation of MSP1 Prevents PfSUB1-Mediated
Processing In Vitro
To begin to address the importance of MSP1 processing, muta-
tions were introduced into a recombinant product called Fwt het-
erodimer (Kauth et al., 2003), which comprises the two ‘‘halves’’
of MSP1-F refolded into a stoichiometric complex. Substitution
of the P2 and P20 positions at the 83/30 site (mutant Fmut83/
30; Figure S1A) ablated cleavage by rPfSUB1 at this position
(Figure S1B). Similarly, a recombinant full-length MSP1-F called
Fwt (Kauth et al., 2006) with P4 and P2 substitutions at the 30/38
site (mutant Fmut30/38; Figure S1A) was refractory to cleavage
at this site (Figure S1C). This showed that appropriate mutations
prevent processing and indicated an absence of alternative sites
at the 83/30 and 30/38 positions in MSP1-F.
To examine the potential for preventing cleavage at the 38/42
sites, we produced further Fwt heterodimer mutants designed to
block cleavage at one or more of these sites, and at a third puta-
tive alternative 38/42 site unique to MSP1-F (Figure 1A). Cleav-
age within the 38/42 region was abolished by simultaneous
mutation of the canonical, alt1, alt2, and putative third alternative
sites, but mutagenesis of only one site, or two sites together, or
the canonical and alt1 sites plus the putative third alternative site,
was insufficient to block cleavage (Figure S1D).
In view of the special importance of the 38/42 site, this analysis
was extended using a full-length recombinant MSP1-D called
rMSP1-DCD4wt. Simultaneous mutagenesis of the canonical,
alt1, and alt2 sites completely blocked cleavage within the 38/
42 region (Figure S1E). Together, these results confirmed the
presence of alternative 38/42 sites in both MSP1 isoforms and
identified mutations that prevent all PfSUB1-mediated cleavage.
PfSUB1 Processing of an MSP1 Transgene Product Is
Important for Parasite Viability
To test whether mutations that prevent processing are tolerated
by P. falciparum, we adopted two complementary strategies.
First, we exploited an episomal transgene expression system
(Epp et al., 2008) that allows blasticidin-regulated control ofCell Hostexpression levels. Constructs for expression of three forms of
MSP1-F (Figure 2A; Figures S2A, and S2B) were transfected
into 3D7 P. falciparum, then antibodies specific for MSP1-F
used to examine transgene expression on the background of
endogenous MSP1-D. Parasites harboring a wild-type msp1-f
transgene (3D7pHBIMFwt), or the same gene with mutations at
all putative 38/42 sites (3D7pHBIMFmut38/42), or at all primary
processing sites (3D7pHBIMFmutall), correctly expressed the
transgene product on developing merozoites at all blasticidin
concentrations tested (Figure 2B; Figure S2C). Varying blastici-
din levels from 2–15 mg ml1 did not affect growth of the
3D7pHBIMFwt line or parasites harboring a control plasmid,
pHBIRH (Figure 2C, top). However, parasites harboring mutant
constructs pHBIMFmut38/42 and pHBIMFmutall showed signif-
icantly lower growth rates than the 3D7pHBIMFwt line (Figure 2C,
bottom). Whereas the 3D7pHBIMFwt line responded to in-
creases in blasticidin concentration by substantially upregulating
msp1-f transcript levels (Figure 2D; Figure S2D), likely via in-
creases in episome copy number (confirmed by copy number
estimation, data not shown), much less upregulation was seen
in the mutant lines, indicating an inability to respond to elevated
drug concentrations. Since the episomes differed only at the
msp1-f cleavage sites, these results suggested that expression
of cleavage-resistant MSP1, even in the presence of endoge-
nous MSP1, is deleterious.
Processing of MSP1 in the 38/42 Region Is Important for
Parasite Viability
In a second approach to evaluating the importance of PfSUB1-
mediated MSP1 processing, we sought to modify the endoge-
nousmsp1 locus using homologous recombination to introduce
mutations that prevent processing within the 38/42 region (the
importance of processing at the 83/30 and 30/38 sites was not
further examined). Our approach used a previously described
strategy (Child et al., 2010) in which we transfected 3D7 para-
sites with constructs containing targeting sequence fused to
synthetic ‘‘recodonized’’ sequence encoding a chimeric MSP1
C-terminal domain (Figure 3A). Integration produces a chimeric
gene, the product of which can be distinguished from unmodi-
fied MSP1-D by its reactivity with the MSP1-F-specific mono-
clonal antibody (mAb) 111.4. Integration thus epitope tags the
gene.
Four integration constructs were initially generated (Figure 3A).
Construct pHH1MSP1chim_wt was designed to replace the 30
region of the msp1 ORF with the chimeric sequence but
leave the 38/42 processing sites unaltered. It thus acted as
a control for all other genetic experiments. Constructs
pHH1MSP1chim_can and pHH1MSP1chim_alt1 were identical
to pHH1MSP1chim_wt except that they were designed to intro-
duce di-leucine mutations at the P2 and P1 positions of the
canonical 38/42 site or the 38/42alt1 site, respectively; these
substitutions blocked processing of recombinant MSP1 (Fig-
ure S1). Construct pHH1MSP1chim_can+alt1 was designed to
introduce both these sets of substitutions upon integration,
thus blocking cleavage at both the canonical and 38/42alt1 sites.
Parasites independently transfected with the constructs were
subjected to drug cycling (growth in the absence then presence
of WR99210) to select for integration. PCR analysis detected
integration of all constructs by drug cycle 2 (data not shown),& Microbe 18, 433–444, October 14, 2015 ª2015 The Authors 435
Figure 2. Episomal Expression of Cleavage-Resistant MSP1 Inhibits P. falciparum Growth
(A) Blasticidin-regulated co-selection episome. A bi-directional P. falciparum promoter (the intron of PlasmoDB: PFC0005w) drives expression of the blasticidin-
S-deaminase gene (bsd) andmsp1-f transgene. The hrp2 gene 30 UTR controls transgene transcript termination and polyadenylation. Three variants were used,
expressing wild-type msp-1f (pHBIMFwt, blue), or with mutations at all four known and putative 38/42 sites, (pHIBMFmut38/42, yellow; same mutations as
Fmut38/42triple, Figure S1A) or mutations at all primary processing sites (pHBIMFmutall, red; same as mutant Fmutall, Figure S1A). All msp1-f sequences
included the GPI anchor sequence. Increasing blasticidin concentration selects for parasites harboring multi-copy concatamers to maintain drug resistance,
leading to increased msp1-f expression. A construct containing the Renilla luciferase gene (pHBIRH, green) was used as control.
(B) Immunofluorescence analysis (IFA) of parental 3D7 and FCB1 schizonts, as well as 3D7 schizonts harboring the constructs in the indicated concentrations of
blasticidin. Parasites were probedwithMSP1 isoform-specific antibodies.Merged signals include that of the DNA dye 4,6-diamidino-2-phenylindole (DAPI, blue).
Scale bar, 5 mm.
(C) Quantification by FACS of parasite replication over a single erythrocytic cycle. Top: no significant differences between parental parasites and the transgenic
3D7pHBIMFwt and 3D7pHBIRH lines. Bottom: replication of the 3D7pHBIMFwt line compared to the 3D7pHIBMFmut38/42 and 3D7pHBIMFmutall lines ex-
pressing mutant MSP1-F, at similar blasticidin concentrations. Columns show mean values of >3 biological replicates. Error bars, SEM. Statistically different
growth rates are indicated (*p < 0.05; **p < 0.01. Kruskal-Wallis test).
(D) Transgene RNA transcript levels measured by qRT-PCR, as a percentile of endogenousmsp1-d transcript levels (100%). SEM values in all cases were <0.1%.
See also Figure S2.
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Figure 3. Mutations that Prevent All Pro-
cessing in the 38/42 Region Are Deleterious
(A) Top: modification of the P. falciparum msp1-d
locus by single-crossover homologous recombi-
nation. The targeting region (gray) incorporated
into the integration constructs was fused just
upstream of the 38/42 region to recodonized
sequence (red/green, syn) encoding the rest of
the ORF. In all except pHH1MSP1chim_wt, this
incorporated mutations and/or deletions to block
processing at one or more 38/42 cleavage sites
(asterisk). The 30 end of the recodonized sequence
(green) contained the MSP1-F-specific mAb 111.4
epitope. Positions of hybridization of primers
used for diagnostic PCR are indicated (blue and
red half arrows). Integration replaced the msp1 30
UTR with that of the P. berghei dihydrofolate
reductase gene (pbdt). The hdhfr cassette confers
resistance to WR99210. Integration produces a
modified locus encoding a chimeric MSP1 recog-
nized by both mAb X509 and mAb 111.4. Bottom:
substitutions or deletions (hyphens) introduced by
the constructs are indicated (red). Green tick,
successful integration. Red cross, no integration
detected.
(B) IFA of schizonts of the parental and transgenic
P. falciparum clones. All transgenics reacted with
mAb 111.4. Scale bar, 5 mm.
(C) Top: schematic of the MSP142 fragment (GPI
anchored) and the slightly larger MSP142* and
MSP142** species predicted to result from ablation
of cleavage at the canonical and canonical plus 38/
42alt1 sites, respectively. The MSP133 and modi-
fied MSP133* and MSP133** fragments, derived
from cleavage by SUB2 within MSP142, MSP142*,
and MSP142**, respectively, are also depicted.
Bottom: western blot shows differences (high-
lighted, dotted lines) in migration of the wild-type
and modified MSP142 forms.
(D) Western blot of culture supernatants shows differences in migration of MSP133, MSP133*, and MSP133** (highlighted as above). As controls, supernatants
were probed with mAb 89.1, which recognizes MSP183, or antibodies to an irrelevant shed parasite protein, AMA1. See also Figure S3.and clones derived from the drug-resistant lines were recog-
nized by mAb 111.4, confirming correct integration (Figure 3B,
top five rows). Sequencing of PCR products amplified from the
modified msp1 locus of the clones confirmed the presence of
the mutations (data not shown).
The transgenic clones grew normally, indicating no effects of
the mutations on viability (data not shown). To assess the impact
on MSP1 processing, schizont extracts and culture supernatants
containing shed MSP1 fragments were examined by western
blot. This showed a shift in migration of the MSP142 cleavage
product in the chim_can and chim_can+alt1 clones (Figure 3C),
with production of progressively larger fragments termed
MSP142* and MSP142**. This was consistent with blockade of
cleavage at the canonical site (chim_can) or at bothmodified sites
(chim_can+alt1), resulting instead in cleavage at the 38/42alt1
site or the 38/42alt2 site, respectively. Examination of culture su-
pernatants (Figure 3D) showed increases in the mass of the shed
MSP133 fragment in the chim_can and chim_can+alt1 clones,
again consistent with ablation of processing at the canonical
38/42 site, or both sites, respectively. To confirm the site of cleav-
age when processing at both the canonical and 38/42alt1 sites
was prevented, we purified the MSP133** species from cultureCell Hostmedium of a chim_can+alt1 clone (Figure S3). Edman degrada-
tion identified its N terminus as NYDEE, confirming the 38/
42alt2 cleavage site and proving the presence of alternative,
redundant 38/42 cleavage sites in MSP1-D. The lack of a growth
defect in the chim_can, chim_alt1, and chim_can+alt1 parasite
clones proved that cleavage at the canonical or 38/42alt1 sites
is not essential; blocking cleavage at one or both positions simply
shifted cleavage to an alternative available 38/42 site.
To examine the effects of blocking processing at all three
38/42 positions, four additional transfection constructs were
generated (Figure 3A). Constructs pHH1MSP1chim_alt2 and
pHH1MSP1chim_triple were designed to introduce mutations
that block cleavage at the 38/42alt2 site or all three 38/42 sites
respectively (Figure S1). In addition, pHH1MSP1chim_D+can
and pHH1MSP1chim_D+mut were designed to delete a 69-
residue predicted unstructured (data not shown) segment of
MSP1 sequence that encompasses both the 38/42alt1 and
38/42alt2 sites. Construct pHH1MSP1chim_D+can was de-
signed to leave the canonical 38/42 site unaltered, whereas
pHH1MSP1chim_D+mut would additionally render this site non-
cleavable. Both pHH1MSP1chim_alt2 and pHH1MSP1chim_
D+can rapidly integrated (data not shown), and the resulting& Microbe 18, 433–444, October 14, 2015 ª2015 The Authors 437
parasite clones showed the expected reactivity with mAb 111.4
(Figure 3B, bottom 2 rows). In contrast, despite five indepen-
dent transfection experiments, each with extended periods
of drug cycling, integration of pHH1MSP1chim_triple and
pHH1MSP1chim_D+mut was never detected. Since, aside from
the mutations unique to these constructs, they were identical to
the other six constructs that readily integrated, this result sug-
gested that cleavage of at least one position within the 38/42 re-
gion of MSP1 is important for parasite viability.
Processing of MSP1 Alters Its Secondary Structure and
Activates Spectrin and Heparin-Binding Activity
Size-exclusion chromatography of rPfSUB1-cleaved rMSP1-
DCD4wt as well as a similar protein lacking the CD4 tag
(rMSP1-Dwt; Figure S1E) showed that, like parasite MSP1
(McBride and Heidrich, 1987), the processed products remain
associated under non-denaturing conditions (Figure S4A). This
encouraged us to use the recombinant proteins to examine the
structural consequences of cleavage. Circular dichroism (CD) of
intact and rPfSUB1-processed rMSP1-Dwt, aswell as of amutant
(rMSP1-Dmut) that was refractory to cleavage in the 38/42 region
(FigureS1E), showedthatprocessingaltered thesecondarystruc-
ture of both proteins (Figure 4A). These changes were less exten-
sive in rMSP1-Dmut, indicating that cleavage at the 38/42 region
contributed to the conformational rearrangements.
MSP1 has been implicated in interactions with erythrocyte
surface heparin-like polysaccharides, so we compared the ca-
pacity of intact and rPfSUB1-cleaved rMSP1-Dwt to bind to im-
mobilized heparin. Cleaved rMSP1-Dwt showed 4-fold higher
binding than intact protein, which was reduced by soluble hepa-
rin (Figure 4B). We next examined the ability of rMSP1-Dwt to
bind to intact erythrocytes. No binding was detected (data not
shown). However, permeabilized erythrocytes incubated with
cleaved rMSP1-Dwt showed an 3.3-fold more intense IFA
signal than cells exposed to intact rMSP1-Dwt (Figure 4C), sug-
gesting that cleavage enhanced binding to an intraerythrocytic
component. This was confirmed in pull-down assays using in-
side-out erythrocyte ghost vesicles (IOVs) (Figure 4D), as well
as by immunoEM analysis of erythrocyte cytoskeletons (Fig-
ure 4E; Figure S4D), which in both cases showed preferential
binding of cleaved rMSP1-Dwt. To determine the target(s) of
binding, we probed SDS PAGE-fractionated erythrocyte ghosts
in overlay assays with intact or rPfSUB1-processed rMSP1-Dwt.
Cleaved rMSP1-Dwt bound exclusively to a Triton X-100-insol-
uble doublet migrating at the positions of a- and b-spectrin,
the dominant components of the cytoskeleton (Figure 4F).
This was confirmed by probing purified spectrin ‘‘spiked’’ with
irrelevant proteins (Figure 4G). No binding was observed
for intact or rPfSUB1-treated rMSP1-DCD4mut (Figure 4H),
showing that cleavage within the 38/42 region—already shown
to be important for parasite viability—was required for binding
to spectrin.
PfSUB1-Mediated Processing of MSP1 Plays a Role in
Egress
The erythrocyte cytoskeleton lies beneath the cell membrane so
merozoites are unlikely to contact it during invasion. However,
intracellular merozoites impinge on the inner face of the host
cell membrane in the brief period between PVM rupture and438 Cell Host & Microbe 18, 433–444, October 14, 2015 ª2015 The Aegress (e.g., Glushakova et al., 2009), so we explored the possi-
bility that direct interactions between processed merozoite sur-
face MSP1 and host cell spectrin might play a part in egress.
For this, we returned to the chim_D+can mutant (Figure 3) in
which an MSP1 segment had been deleted to remove the 38/
42alt1 and 38/42alt2 sites entirely, leaving just the canonical
38/42 cleavage site. Since this is a relatively poor substrate for
PfSUB1 (Figure 1C), we predicted that cleavage within the 38/
42 region in the chim_D+can mutant should be less efficient
than inwild-type parasites. To test this,we compared the kinetics
of processing in chim_D+can parasites with that in chim_wt par-
asites, which expressed the same chimericMSP1 but retained all
three 38/42 cleavage sites. For these experiments, schizonts
were treated with the reversible PKG inhibitor compound 1
(C1), which prevents PfSUB1 discharge, stalling schizont devel-
opment at the final stage of maturation. MSP1 processing and
egressoccurwithinminutes ofwashing away the inhibitor (Collins
et al., 2013b). As shown in Figure 5A, processing of MSP1 in the
chim_D+can mutant was delayed relative to chim_wt parasites
and was characterized by an unusually prominent MSP138+42
processing intermediate. Comparison of the kinetics of chim_
D+can and chim_wt egress by time-lapse microscopy showed
a reproducible delay in egress in the chim_D+can parasites
following C1 removal (Figure 5B; Movie S1), mirroring the delay
in MSP1 processing. This was confirmed in further experiments
in which the clones were imaged simultaneously following fluo-
rescent labeling of one population to identify it (Movie S2; Fig-
ure S5). Since the chim_D+can and chim_wt parasites differed
only by the presence or absence of an MSP1 segment encom-
passing the 38/42alt1 and alt2 cleavage sites, these results
showed that processingofMSP1 regulates the kinetics of egress.
Truncation of MSP1 to Remove Its Merozoite Surface
Anchor Produces an Egress Defect
MSP1 is tethered to the merozoite surface via a C-terminal GPI
anchor. To further test our model that direct interactions be-
tween merozoite-bound MSP1 and the erythrocyte cytoskeleton
facilitates egress, we used a recently published conditional strat-
egy to generate P. falciparum transgenics in which a 30 segment
of the msp1 gene could be deleted by rapamycin (RAP)-induc-
ible, Cre recombinase-mediated excision (Figure 6A; Figure S6A)
(Collins et al., 2013a). This was predicted to generate a truncated
MSP1 that lacked aGPI anchor and sowould not be bound to the
merozoite surface. Analysis of RAP-treated 3D7MSP1flox42C
parasites showed highly efficient excision, resulting in exclusive
expression of truncated MSP1 in mature schizonts at the end of
the same erythrocytic cycle (Figures 6B and 6C). No effects on
merozoite development were discernible. The modified MSP1
was trafficked to the PV as expected for a non-membrane-
bound merozoite surface protein (Figures 6C–6D; Figure S6B)
but was not present on the surface of freemerozoites (Figure 6E).
Video microscopy of the RAP-treated 3D7MSP1flox42C schiz-
onts revealed a dramatic egress defect characterized by abor-
tive erythrocyte membrane rupture and trapping of the merozo-
ites in the partially ruptured cell (Figure 6F; Movies S3 and S4).
Consistent with this, the RAP-treated mutants displayed a sub-
stantially reduced replication rate (Figure 6G and Figure S6C).
These results show that MSP1 functions at egress and that
this role requires it to be tethered to the merozoite surface.uthors
Figure 4. Processing Alters MSP1 Second-
ary Structure and Activates a Heparin and
Spectrin-Binding Activity
(A) Far-UV CD spectra of rMSP1-Dwt and rMSP1-
Dmut as a function of molar absorptivity at 37C.
The vertical double arrow at 222 nm (negative
minimum for the alpha helix spectrum) highlights
the reduction in CD intensity following cleavage,
which was 1.4-fold greater for rMSP1-Dwt than for
rMSP1-Dmut. Below: secondary structure com-
position of the intact and processed proteins.
(B) Processing enhances heparin binding. Intact or
cleaved rMSP1-Dwt was incubated with heparin
agarose ± soluble heparin (1 mg ml1), then bind-
ing assessed by SDSPAGE. Quantification of band
intensity (Image Lab) showed that 72.3%± 6.5% of
cleaved rMSP1-Dwt bound heparin agarose but
only 18.3% ± 12.1% of intact rMSP1-Dwt (p =
0.006, Student’s t test).
(C) Fixed, permeabilized erythrocytes probed with
intact or rPfSUB1-cleaved rMSP1-Dwt. Binding
was detected by IFA and imaged using equal
exposure times. Mean pixel intensity (Adobe Pho-
toshop Histogram tool) was 41.6 ± 4.7 (cleaved)
and 12.6 ± 1.4 (uncleaved). Scale bar, 5 mm.
(D) Processing enhances binding to IOVs. Vesicles
(80 mg protein) incubated with intact or rPfSUB1-
cleaved rMSP1-Dwt (4 mg) were washed then two
different loadings analyzed by western blot in
parallel with a 1:1 mixture of the starting protein
preparations.
(E) Processing enhances binding to the erythrocyte
cytoskeleton. Mean density of bound gold beads
following immunoEM of Triton X-100-treated
erythrocyte ghosts incubated with intact or
rPfSUB1-cleaved rMSP1-Dwt then probed with
anti-MSP1 antibodies and 5 nm gold-conjugated
secondary antibodies. Error bars, SD.
(F) Overlay assay. Erythrocyte ghosts or Triton X-
100-fractionated ghosts were separated by SDS
PAGE, transferred to nitrocellulose, then probed
with rPfSUB1-cleaved or intact rMSP1-Dwt and
binding detected with anti-MSP1 antibodies.
(G) Overlay assay. Erythrocyte ghosts, or purified
erythrocyte spectrin (Sigma) mixed with molecular
mass marker proteins (GE Healthcare), were sub-
jected to SDS PAGE and either stained or trans-
ferred to nitrocellulose and probed as in (F) with
rPfSUB1-cleaved rMSP1-Dwt.
(H) Overlay assay. Erythrocyte ghosts probed as in
(F) with intact or rPfSUB1-cleaved rMSP1-DCD4wt
or rMSP1-DCD4mut. The latter, which is refractory
to cleavage in the 38/42 region, did not bind
spectrin. See also Figure S4.Collectively, our findings support the model that processing of
MSP1 facilitates host cell membrane rupture, probably through
interactions between the mature merozoite surface and the
erythrocyte cytoskeleton.
DISCUSSION
We have combined genetic, structural, and functional analysis
with microscopic observation of egress to produce evidenceCell Hostthat: (1) proteolytic maturation of MSP1 by SUB1 is important
for parasite viability; (2) proteolysis alters MSP1 secondary
structure, conferring upon it a capacity to bind to both heparin
and erythrocyte spectrin; and (3) these functional alterations
regulate egress, probably as a result of interactions between
MSP1 and the host cell cytoskeleton. The resistance of the eryth-
rocyte membrane to mechanical shear stress is dependent on
the structural integrity of its cytoskeleton and in particular its un-
derlying lattice of spectrin tetramers formed by the head-to-head& Microbe 18, 433–444, October 14, 2015 ª2015 The Authors 439
Figure 5. Rate of MSP1 Processing Regu-
lates the Kinetics of Egress
(A) Top: the 38/42 region in chim_D+can and
chim_wt parasites and the MSP1 processing
pathway (Child et al., 2010). Bottom: time course
comparing processing of MSP1 from chim_D+can
and chim_wt clones by western blot. Schizonts
were sampled at the indicated times following
removal of a C1 block. Note the slightly smaller full-
length chim_D+can MSP1 due to the 69-residue
deletion.
(B) Left: stills from time-lapse microscopy of
chim_D+can and chim_wt clones (imaging started
4 min 20 s after C1 removal). Right: box plot
comparison of time to egress after C1 removal.
Data are from 4 independent experiments each
assessing 12–24 egress events per clone. Whis-
kers, range. A single outlier point (>1.53 the in-
terquartile range) indicated. The chim_D+can
clones showed a mean egress delay of 7.5 ±
1.4 min (p < 0.005, Student’s t test). Similar results
were obtained with two other chim_D+can and
chim_wt clones (data not shown). See also Fig-
ure S5 and Movies S1 and S2.association of pairs of ab spectrin heterodimers. The spectrin
network is dynamic, accommodating reversible breakage and
reformation of the dimer-dimer bonds in response to even mod-
erate shear stress (e.g., Salomao et al., 2006). Shear forces can
also result in unfolding of the triple-helical repeat units that
comprise a- and b-spectrin, providing additional flexibility (Ran-
dles et al., 2007). This dynamic state allows peptides and other
small molecules that interfere with tetramer stability (Salomao
et al., 2006) or that perturb interactions between spectrin and
other cytoskeletal components such as ankyrin (Blanc et al.,
2010), protein 4.1R, and actin (An et al., 2007) to destabilize
the membrane. SUB1-processed MSP1 may perform an analo-
gous role. We speculate that following PVM breakdown, the
diffusive movement of intracellular merozoites impinging upon
the inner face of the erythrocyte membrane—well documented
by both time-lapse and diffraction phase microscopy (Chandra-
mohanadas et al., 2011; Gilson and Crabb, 2009; Glushakova
et al., 2010; Glushakova et al., 2009) (see also Movie S5)—en-
ables merozoite surface-bound MSP1 to bind the spectrin lat-440 Cell Host & Microbe 18, 433–444, October 14, 2015 ª2015 The Authorstice, producing internal shear forces that
disrupt the cytoskeleton (Figure 7). This
is likely aided by protease activity,
perhaps involving host cell calpain-1
(Chandramohanadas et al., 2009) and/or
the PfSUB1 substrate SERA6 (Ruecker
et al., 2012), since the cysteine protease
inhibitor E64 selectively inhibits host cell
membrane rupture (e.g., Glushakova
et al., 2009). Even localized destabiliza-
tion of the cytoskeleton may be sufficient
to allow egress, since high-speed video
microscopy has shown that erythrocyte
membrane rupture initiates at a single
site; subsequent elastic inversion of the
membrane promotes its rapid disintegra-
tion (Abkarian et al., 2011; Crick et al., 2013). Interestingly,
Herrera et al. (1993) reported spectrin-binding activity for a re-
combinant MSP1 polypeptide, suggested by those authors as
being important for intracellular parasite development. We do
not favor that model, since parasites replicate within the PVM,
which shields them from the host cytoskeleton. In contrast, the
egress delay observed in the chim_D+can mutant, and the
egress defect (with no effect on schizont development) when
MSP1 is conditionally converted to a non merozoite-bound
form, implies a role for processed merozoite-bound MSP1 in
host cell rupture. Our model explains the defect associated
with episomal expression of cleavage-resistant MSP1 (Figure 2),
which presumably reduces egress efficiency by reducing the
proportion of MSP1 at the merozoite surface able to interact
with the host cell cytoskeleton. These data implicate a surface
protein in the egress of an intracellular non-viral pathogen.
They also provide a plausible mechanistic rationale for the timing
of MSP1 processing by SUB1, which ‘‘prepares’’ the merozoites
for partaking in their own release.
Figure 6. Truncation of MSP1 Produces an
Egress Defect
(A) Predicted RAP-induced MSP1 truncation in the
3D7MSP1flox42C clones, showing loss of the GPI
anchor and C-terminal domain containing the mAb
X509 epitope.
(B) MSP1 truncation confirmed by western blot of
3D7MSP1flox42C1 clone E3 schizonts, 44 hr
following treatment ± RAP. The PV protein SERA5
was used as a loading control.
(C) RAP treatment produces a loss of mAb X509
reactivity and a shift in the IFA pattern of MSP1 to
one typical of PV proteins, consistent with the
predicted truncation. Numbers of DAPI-stained
nuclei did not differ between control and RAP-
treated schizonts (mean values: 21.2 ± 3.4 and
20.6 ± 4.0 nuclei per schizont, respectively, n = 24).
(D) IFA showing co-localization of truncated MSP1
with SERA5 indicating a PV location. The punctate
localization of SUB1 and the microneme protein
AMA1 indicates normal organelle biogenesis.
(E) IFA showing lack of surface-bound MSP1 on
merozoites of RAP-treated 3D7MSP1flox42C1
clone E3. Antibodies to AMA1 (which is expressed
on free merozoites) were used as a control.
(F) Stills from time-lapse DIC microscopic
imaging of egress in control and RAP-treated
3D7MSP1flox42C1 clone E3. Scale bar, 10 mm.
(G) Replication rates of RAP- or control-treated
3D7MSP1flox42C1 clone E3. Cultures were
passaged at intervals by 10-fold dilution into fresh
medium plus erythrocytes as described in Supple-
mental Experimental Procedures. Observed para-
sitaemia values were adjusted for these dilutions
and are displayed as adjusted values. The plot
shows mean values of three biological replicate
experiments. Error bars, SEM. The RAP-treated
cultures showed an 2.1-fold reduction in replica-
tion rate per cycle, but this was an over-estimate of
mutant viability due to rapid expansion of the few
(1%) non-excised parasites in the RAP-treated
cultures. See also Figure S6 andMovies S3 and S4.We do not rule out additional roles for MSP1. A previous report
(Combe et al., 2009) showed that knockdown of MSP1 expres-
sion in parasite liver stages ablated merozoite formation, sug-
gesting a role in merozoite budding. Additionally, our observation
that processing enhances binding to heparin tempts speculation
that SUB1 may activate MSP1 to perform a function at invasion.
However, the fact that RAP-treated 3D7MSP1flox42C parasites
lacking surface-bound MSP1 produce normal numbers of mero-
zoites and replicate in vitro (albeit at a very reduced rate) shows
that merozoite surface MSP1 is dispensable for merozoite devel-
opment and invasion in blood stages. Compounds that inhibit
MSP1 processing or that block interactions with spectrin may
form the basis of antimalarial drugs that interfere with this key
step in the malarial life cycle.
EXPERIMENTAL PROCEDURES
Parasite Culture, Transfection, and Growth Assays
P. falciparum clones FCB1, 3D7, and 1G5DC (Collins et al., 2013a) were main-
tained in RPMI 1640mediumwith Albumax (Invitrogen) and synchronized using
standard procedures (Blackman, 1994). Transfection, selection with WR99210Cell Host(Jacobus Pharmaceuticals), and cloning was as described (Collins et al., 2013a;
Harris et al., 2005). Growth rates were determined by microscopy or fluores-
cence-activated cell sorting (FACS) as described (Stallmach et al., 2015). De-
tails of transfection constructs based on the pHBIRH episome (Epp et al.,
2008) and integration plasmid pMSP1chimWT (Child et al., 2010) are provided
in Supplemental Experimental Procedures, as are details of the construct used
to flank a segment of the 1G5DCmsp1ORFwith loxP sites. For conditional trun-
cation of MSP1 in the 3D7MSP1flox42C clones, synchronous ring-stage para-
sites were treated for 4 hr with 100 nM RAP (Collins et al., 2013a).
Recombinant Proteins and Antibodies
Monoclonal antibodies 89.1, X509, and 111.4, rabbit polyclonal antibodies and
their use in western blot and IFA analysis have been described (Blackman
et al., 1991; Child et al., 2010; Ruecker et al., 2012). Production and purification
of rPfSUB1, Fwt, and Fwt heterodimer was as described (Kauth et al., 2003,
2006; Withers-Martinez et al., 2012). Mutants of Fwt and Fwt heterodimer
were produced using QuikChange II (Agilent) site-directed mutagenesis of
parent plasmids. For rMSP1-Dwt, MSP1-D (minus its GPI anchor) was ex-
pressed in HEK293E cells (Crosnier et al., 2013); for rMSP1-DCD4wt, it was
fused to domains 3 and 4 of rat CD4. Cleavage site mutants were produced
by replacing segments of the expression constructs with synthetic gene frag-
ments containing substitutions. The proteins were purified by nickel chelate
and size-exclusion chromatography.& Microbe 18, 433–444, October 14, 2015 ª2015 The Authors 441
Figure 7. Model for the Role of MSP1 Processing in Egress
See also Movie S5.Peptide Cleavage Assays and N-Terminal Sequencing
Synthetic peptides were from Biomatik (http://www.biomatik.com). Peptide
cleavage assays and product identification by RP-HPLC and mass spectrom-
etry were as described (Koussis et al., 2009; Withers-Martinez et al., 2012). To
purify shedMSP1 fragments, 3D7 or chim_can+alt1 schizonts were allowed to
undergo egress in protein-free medium then the supernatants fractionated on
a Vydac 4.6 3 150 mm 214TP C4 RP-HPLC column. The MSP133 and
MSP133** species were identified by western blot then the proteins transferred
to PVDF membrane for N-terminal sequencing (PNAC).
Quantitative Real-Time PCR
First strand cDNA synthesis was performed using a SuperScript II First-Strand
Synthesis Kit (Invitrogen) according to the manufacturer’s instructions. Quan-
titative real-time PCR (qRT-PCR) was performed using the ABI 7500 sequence
detection system and a SensiFASTSYBR Lo-ROX kit (Bioline). Data were
analyzed with SDS 1.3.1 software (Applied Biosystems). Transgene expres-
sion was displayed as a percentile of endogenousmsp1-d expression (100%).
Circular Dichroism and Secondary Structure Predictions
Purified rMSP1-Dwt and rMSP1-Dmut (0.156 mgml1 in 500 ml 25 mMHEPES
[pH 7.4], 150 mM NaCl, 15 mM CaCl2) were monitored on a Jasco J-715
spectropolarimeter for 5 hr at 37C with or without added rPfSUB1 (6 ml at
0.84 mg ml1). Secondary structure composition was averaged using
CONTINLL, SELCON3, and CDSSTR (Sreerama and Woody, 2004). Second-
ary structure predictions were performed with JPred (http://www.compbio.
dundee.ac.uk/www-jpred/).
Heparin-Binding, Overlay Assays, IOV Pulldown Assays and
immunoEM
Heparin-agarose beads (Sigma) in assay buffer (25 mM HEPES [pH 7.4],
15 mM NaCl, 0.07% Tween 20) were incubated with intact or cleaved
rMSP1-Dwt (50 ml at 0.1 mg ml1). Control samples were additionally supple-
mented with heparin sodium salt (1 mg ml1, Sigma). Following incubation
for 20 min at room temperature, supernatants containing unbound proteins442 Cell Host & Microbe 18, 433–444, October 14, 2015 ª2015 The Awere recovered and the beads washed five times with assay buffer. Bound
proteins were eluted into 50 ml SDS sample buffer then all samples subjected
to reducing SDS-PAGE on a 4%–16% gradient gel. The gel was stained with
Coomassie blue, imaged using a BioRad Chemidoc MP system and band in-
tensities estimated using Image Lab software.
Overlay assays to detect binding to SDS-PAGE fractionated human erythro-
cyte ghost proteins were as described by Herrera et al. (1993). IOVs were pre-
pared using standard procedures from erythrocyte ghosts (see Supplemental
Experimental Procedures) and incubated in PBS with intact or rPfSUB1-
cleaved rMSP1-Dwt, rMSP1-DCD4wt, or rMSP1-DCD4mut before washing
and analysis by western blot, detecting bound proteins with mAb 89.1. For im-
munoEM analysis, TX-100-treated cytoskeletons immobilized on grid grids
were incubated with intact or cleaved rMSP1-Dwt (0.1 mg ml1) then washed
and probed with anti-MSP1 antibodies followed by 5 nm gold-conjugated
anti-rabbit IgG, before staining with sodium silicotungstate.
Time-Lapse Microscopy
P. falciparum egress was imaged as described (Collins et al., 2013b), using C1
to synchronize egress. Microscopic DIC images were routinely collected at 5 s
intervals for up to 30 min. For comparison of 3D7 chim_D+can and 3D7
chim_wt parasites, populations were either alternately imaged or combined
in the same microscopy chamber after labeling one mutant with Hoechst
33342 prior to washing away C1. An initial fluorescence image was collected
prior to starting the time-lapse DIC imaging, then the fluorescence and first
DIC images overlayed to identify labeled cells. Image files were exported as
AVI movies using Axiovision 3.1 software. Time to individual egress events
was recorded by visual examination of movie frames.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, two tables, and fivemovies and can be found with this article online
at http://dx.doi.org/10.1016/j.chom.2015.09.007.uthors
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